secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0000950103-24-017767
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River amends credit agreement, cuts revolver to $2B, extends to 2029
----------------------------------------------------------------------------

- Revolving commitments reduced from $3B to $2B; maturity extended to December 13, 2029.
- Subsidiary borrower Charles River Laboratories, Inc. added; obligations guaranteed by CRL and secured by assets.
- Interest rates based on SOFR/EURIBOR/Base rate plus margin tied to leverage ratio (Level I-III).
- Negative covenants limit additional indebtedness, liens, investments, mergers, and asset sales.
- Covenants include interest coverage and leverage ratio tests; customary events of default.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000095010324017767/0000950103-24-017767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000095010324017767/dp222024_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-017767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer